Serum levels of soluble CD30 in autologous peripheral blood stem cell transplantation View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2000-01

AUTHORS

Minori Nagahama, Shosaku Nomura, Kaoruko Katsura, Yoshio Ozaki, Chie Yoshimura, Hideo Kagawa, Shirou Fukuhara

ABSTRACT

High-dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) has become an important method of treatment for hematological and solid tumors. We examined levels of interleukin(IL)-4, interferon (IFN)gamma, soluble (s) CD30, and sIL-2 receptor (R) before and after autologous PBSCT, and compared findings for PBSCT with those for bone marrow transplantation (BMT). We found significantly higher IL-4 levels 1 and 3 weeks after PBSCT than before PBSCT, while IFNgamma levels remained almost unchanged after PBSCT. IFNgamma levels were increased 3 weeks after BMT, although no increase in IL-4 level was observed. The serum sCD30 level was significantly higher 3 weeks after PBSCT, but not following BMT. For 34 samples on days 0 and 21 from 17 patients undergoing PBSCT, a strong correlation was observed between sCD30 and sIL-2R levels (r = 0.43, P < 0.01). However, no significant correlation between sCD30 and sIL-2R levels was found for BMT patients. These findings suggest that sCD30 is a useful marker for evaluating immunological activity following autologous PBSCT, and that the immunological conditions after autologous PBSCT may be associated with helper-T-cell-2-type immune responses. More... »

PAGES

101-106

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/pl00008480

DOI

http://dx.doi.org/10.1007/pl00008480

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1017898130

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10664250


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Histocompatibility Antigens Class II", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interferon-gamma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Interleukin-4", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ki-1 Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoma, Non-Hodgkin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Interleukin-2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation, Autologous", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Kansai Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410783.9", 
          "name": [
            "The First Department of Internal Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi Osaka 570-8506, Japan e-mail: fwkg4681@mb.infoweb.ne.jp Tel.: +81-6-6992-1001 Fax: +81-6-6994-8344, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nagahama", 
        "givenName": "Minori", 
        "id": "sg:person.0753230246.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753230246.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kansai Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410783.9", 
          "name": [
            "The First Department of Internal Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi Osaka 570-8506, Japan e-mail: fwkg4681@mb.infoweb.ne.jp Tel.: +81-6-6992-1001 Fax: +81-6-6994-8344, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nomura", 
        "givenName": "Shosaku", 
        "id": "sg:person.0637542245.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637542245.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kansai Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410783.9", 
          "name": [
            "The First Department of Internal Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi Osaka 570-8506, Japan e-mail: fwkg4681@mb.infoweb.ne.jp Tel.: +81-6-6992-1001 Fax: +81-6-6994-8344, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Katsura", 
        "givenName": "Kaoruko", 
        "id": "sg:person.01173636554.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173636554.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kansai Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410783.9", 
          "name": [
            "The First Department of Internal Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi Osaka 570-8506, Japan e-mail: fwkg4681@mb.infoweb.ne.jp Tel.: +81-6-6992-1001 Fax: +81-6-6994-8344, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ozaki", 
        "givenName": "Yoshio", 
        "id": "sg:person.01277017443.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277017443.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kansai Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410783.9", 
          "name": [
            "The First Department of Internal Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi Osaka 570-8506, Japan e-mail: fwkg4681@mb.infoweb.ne.jp Tel.: +81-6-6992-1001 Fax: +81-6-6994-8344, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yoshimura", 
        "givenName": "Chie", 
        "id": "sg:person.01311004421.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311004421.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kansai Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410783.9", 
          "name": [
            "The First Department of Internal Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi Osaka 570-8506, Japan e-mail: fwkg4681@mb.infoweb.ne.jp Tel.: +81-6-6992-1001 Fax: +81-6-6994-8344, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kagawa", 
        "givenName": "Hideo", 
        "id": "sg:person.01057753270.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057753270.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kansai Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410783.9", 
          "name": [
            "The First Department of Internal Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi Osaka 570-8506, Japan e-mail: fwkg4681@mb.infoweb.ne.jp Tel.: +81-6-6992-1001 Fax: +81-6-6994-8344, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fukuhara", 
        "givenName": "Shirou", 
        "id": "sg:person.011002766332.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011002766332.56"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2000-01", 
    "datePublishedReg": "2000-01-01", 
    "description": "High-dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) has become an important method of treatment for hematological and solid tumors. We examined levels of interleukin(IL)-4, interferon (IFN)gamma, soluble (s) CD30, and sIL-2 receptor (R) before and after autologous PBSCT, and compared findings for PBSCT with those for bone marrow transplantation (BMT). We found significantly higher IL-4 levels 1 and 3 weeks after PBSCT than before PBSCT, while IFNgamma levels remained almost unchanged after PBSCT. IFNgamma levels were increased 3 weeks after BMT, although no increase in IL-4 level was observed. The serum sCD30 level was significantly higher 3 weeks after PBSCT, but not following BMT. For 34 samples on days 0 and 21 from 17 patients undergoing PBSCT, a strong correlation was observed between sCD30 and sIL-2R levels (r = 0.43, P < 0.01). However, no significant correlation between sCD30 and sIL-2R levels was found for BMT patients. These findings suggest that sCD30 is a useful marker for evaluating immunological activity following autologous PBSCT, and that the immunological conditions after autologous PBSCT may be associated with helper-T-cell-2-type immune responses.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/pl00008480", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1313647", 
        "issn": [
          "0171-5216", 
          "1432-1335"
        ], 
        "name": "Journal of Cancer Research and Clinical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "126"
      }
    ], 
    "name": "Serum levels of soluble CD30 in autologous peripheral blood stem cell transplantation", 
    "pagination": "101-106", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "554748c0fd2c29f3bd585a4351688200460218f38cf08cf9e5d5cbdffaef5f56"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10664250"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7902060"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/pl00008480"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1017898130"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/pl00008480", 
      "https://app.dimensions.ai/details/publication/pub.1017898130"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:34", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000480.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/PL00008480"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/pl00008480'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/pl00008480'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/pl00008480'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/pl00008480'


 

This table displays all metadata directly associated to this object as RDF triples.

167 TRIPLES      20 PREDICATES      43 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/pl00008480 schema:about N02340dcbb67f4e42827cbf8f2747e309
2 N031e4dae3f4f4e878dd692c684a78d77
3 N2d09423112fe41208dac65a65abe40bb
4 N3c8eb6806f344ae3ac36e83421af1700
5 N56dbb9b3de454c2b9c2f8488053b71fe
6 N5a382e1a68364a718750b8832918ca02
7 N71c7aaa5cfdd4bd6b13abccd177bf00b
8 N79fca14f5d8c426b8d4546cacee672b0
9 N873a01d26eb6489782b00ad14d2a93ce
10 Naa0da0035b4045d18a4ac0042b9c962c
11 Nae90c6ec353640cb9b8f5cefa72ae7f8
12 Nc1f9a77fbbaa49e59b91d861a101ee42
13 Nccf210f4b6fc41c0acda06d990863758
14 Nf99bbf68a01b464dbc90cec02b708b3e
15 anzsrc-for:11
16 anzsrc-for:1107
17 schema:author Nf19be8b0726f4556858400c5ecdcb414
18 schema:datePublished 2000-01
19 schema:datePublishedReg 2000-01-01
20 schema:description High-dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) has become an important method of treatment for hematological and solid tumors. We examined levels of interleukin(IL)-4, interferon (IFN)gamma, soluble (s) CD30, and sIL-2 receptor (R) before and after autologous PBSCT, and compared findings for PBSCT with those for bone marrow transplantation (BMT). We found significantly higher IL-4 levels 1 and 3 weeks after PBSCT than before PBSCT, while IFNgamma levels remained almost unchanged after PBSCT. IFNgamma levels were increased 3 weeks after BMT, although no increase in IL-4 level was observed. The serum sCD30 level was significantly higher 3 weeks after PBSCT, but not following BMT. For 34 samples on days 0 and 21 from 17 patients undergoing PBSCT, a strong correlation was observed between sCD30 and sIL-2R levels (r = 0.43, P < 0.01). However, no significant correlation between sCD30 and sIL-2R levels was found for BMT patients. These findings suggest that sCD30 is a useful marker for evaluating immunological activity following autologous PBSCT, and that the immunological conditions after autologous PBSCT may be associated with helper-T-cell-2-type immune responses.
21 schema:genre research_article
22 schema:inLanguage en
23 schema:isAccessibleForFree false
24 schema:isPartOf Nbe6afe93a2914be9a6e4a62f691ac16a
25 Ne301da19e81e41f6b30f0142fc0e0963
26 sg:journal.1313647
27 schema:name Serum levels of soluble CD30 in autologous peripheral blood stem cell transplantation
28 schema:pagination 101-106
29 schema:productId N05db8016787e4b3bb6d356e8afee4dbe
30 N439fad527462405498ee343cf4e14869
31 N54b8c911fbbf4409a2535b4c9d31f185
32 N6cd55bf0386647e4a8a1eb589d90d35c
33 Nd1f91c01dd2448eba5366f03a2e2a0e5
34 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017898130
35 https://doi.org/10.1007/pl00008480
36 schema:sdDatePublished 2019-04-10T16:34
37 schema:sdLicense https://scigraph.springernature.com/explorer/license/
38 schema:sdPublisher N7cbfb94a9ead495ba37ccaea6e69c32c
39 schema:url http://link.springer.com/10.1007/PL00008480
40 sgo:license sg:explorer/license/
41 sgo:sdDataset articles
42 rdf:type schema:ScholarlyArticle
43 N02340dcbb67f4e42827cbf8f2747e309 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
44 schema:name Adult
45 rdf:type schema:DefinedTerm
46 N031e4dae3f4f4e878dd692c684a78d77 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
47 schema:name Receptors, Interleukin-2
48 rdf:type schema:DefinedTerm
49 N05db8016787e4b3bb6d356e8afee4dbe schema:name doi
50 schema:value 10.1007/pl00008480
51 rdf:type schema:PropertyValue
52 N2d09423112fe41208dac65a65abe40bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
53 schema:name Middle Aged
54 rdf:type schema:DefinedTerm
55 N3c8eb6806f344ae3ac36e83421af1700 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
56 schema:name Lymphoma, Non-Hodgkin
57 rdf:type schema:DefinedTerm
58 N439fad527462405498ee343cf4e14869 schema:name nlm_unique_id
59 schema:value 7902060
60 rdf:type schema:PropertyValue
61 N547e46247beb491396f905d902496f8d rdf:first sg:person.01277017443.25
62 rdf:rest Nabf8bbbab1dd452984b3ad4d5ba58efb
63 N54b8c911fbbf4409a2535b4c9d31f185 schema:name dimensions_id
64 schema:value pub.1017898130
65 rdf:type schema:PropertyValue
66 N56dbb9b3de454c2b9c2f8488053b71fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Female
68 rdf:type schema:DefinedTerm
69 N5a382e1a68364a718750b8832918ca02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Leukemia
71 rdf:type schema:DefinedTerm
72 N6bb1019cc203412ba8a22aaa7b45658a rdf:first sg:person.01057753270.05
73 rdf:rest N991e5078c7a94f8e9c4070fdf39dda08
74 N6cd55bf0386647e4a8a1eb589d90d35c schema:name readcube_id
75 schema:value 554748c0fd2c29f3bd585a4351688200460218f38cf08cf9e5d5cbdffaef5f56
76 rdf:type schema:PropertyValue
77 N71c7aaa5cfdd4bd6b13abccd177bf00b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Histocompatibility Antigens Class II
79 rdf:type schema:DefinedTerm
80 N79fca14f5d8c426b8d4546cacee672b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Humans
82 rdf:type schema:DefinedTerm
83 N7cbfb94a9ead495ba37ccaea6e69c32c schema:name Springer Nature - SN SciGraph project
84 rdf:type schema:Organization
85 N7d725942a6ea41329535a2c1bf8da80a rdf:first sg:person.0637542245.62
86 rdf:rest Ned2ed4a286c945a1951b8c0c260e2a07
87 N873a01d26eb6489782b00ad14d2a93ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Male
89 rdf:type schema:DefinedTerm
90 N991e5078c7a94f8e9c4070fdf39dda08 rdf:first sg:person.011002766332.56
91 rdf:rest rdf:nil
92 Naa0da0035b4045d18a4ac0042b9c962c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Hematopoietic Stem Cell Transplantation
94 rdf:type schema:DefinedTerm
95 Nabf8bbbab1dd452984b3ad4d5ba58efb rdf:first sg:person.01311004421.55
96 rdf:rest N6bb1019cc203412ba8a22aaa7b45658a
97 Nae90c6ec353640cb9b8f5cefa72ae7f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Interferon-gamma
99 rdf:type schema:DefinedTerm
100 Nbe6afe93a2914be9a6e4a62f691ac16a schema:issueNumber 2
101 rdf:type schema:PublicationIssue
102 Nc1f9a77fbbaa49e59b91d861a101ee42 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Ki-1 Antigen
104 rdf:type schema:DefinedTerm
105 Nccf210f4b6fc41c0acda06d990863758 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Transplantation, Autologous
107 rdf:type schema:DefinedTerm
108 Nd1f91c01dd2448eba5366f03a2e2a0e5 schema:name pubmed_id
109 schema:value 10664250
110 rdf:type schema:PropertyValue
111 Ne301da19e81e41f6b30f0142fc0e0963 schema:volumeNumber 126
112 rdf:type schema:PublicationVolume
113 Ned2ed4a286c945a1951b8c0c260e2a07 rdf:first sg:person.01173636554.12
114 rdf:rest N547e46247beb491396f905d902496f8d
115 Nf19be8b0726f4556858400c5ecdcb414 rdf:first sg:person.0753230246.06
116 rdf:rest N7d725942a6ea41329535a2c1bf8da80a
117 Nf99bbf68a01b464dbc90cec02b708b3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Interleukin-4
119 rdf:type schema:DefinedTerm
120 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
121 schema:name Medical and Health Sciences
122 rdf:type schema:DefinedTerm
123 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
124 schema:name Immunology
125 rdf:type schema:DefinedTerm
126 sg:journal.1313647 schema:issn 0171-5216
127 1432-1335
128 schema:name Journal of Cancer Research and Clinical Oncology
129 rdf:type schema:Periodical
130 sg:person.01057753270.05 schema:affiliation https://www.grid.ac/institutes/grid.410783.9
131 schema:familyName Kagawa
132 schema:givenName Hideo
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01057753270.05
134 rdf:type schema:Person
135 sg:person.011002766332.56 schema:affiliation https://www.grid.ac/institutes/grid.410783.9
136 schema:familyName Fukuhara
137 schema:givenName Shirou
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011002766332.56
139 rdf:type schema:Person
140 sg:person.01173636554.12 schema:affiliation https://www.grid.ac/institutes/grid.410783.9
141 schema:familyName Katsura
142 schema:givenName Kaoruko
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173636554.12
144 rdf:type schema:Person
145 sg:person.01277017443.25 schema:affiliation https://www.grid.ac/institutes/grid.410783.9
146 schema:familyName Ozaki
147 schema:givenName Yoshio
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277017443.25
149 rdf:type schema:Person
150 sg:person.01311004421.55 schema:affiliation https://www.grid.ac/institutes/grid.410783.9
151 schema:familyName Yoshimura
152 schema:givenName Chie
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311004421.55
154 rdf:type schema:Person
155 sg:person.0637542245.62 schema:affiliation https://www.grid.ac/institutes/grid.410783.9
156 schema:familyName Nomura
157 schema:givenName Shosaku
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637542245.62
159 rdf:type schema:Person
160 sg:person.0753230246.06 schema:affiliation https://www.grid.ac/institutes/grid.410783.9
161 schema:familyName Nagahama
162 schema:givenName Minori
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753230246.06
164 rdf:type schema:Person
165 https://www.grid.ac/institutes/grid.410783.9 schema:alternateName Kansai Medical University
166 schema:name The First Department of Internal Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi Osaka 570-8506, Japan e-mail: fwkg4681@mb.infoweb.ne.jp Tel.: +81-6-6992-1001 Fax: +81-6-6994-8344, JP
167 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...